Related Experiment Video
Updated: Nov 2, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
TP53 Disruption in Chronic Lymphocytic Leukemia Under Ibrutinib: More is Worse?
Riccardo Bomben1, Antonella Zucchetto1, Massimo Gentile2
1Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
Abstract:
Patients with chronic lymphocytic leukemia carrying a single TP53 hit (chromosome 17p deletion or single TP53 mutation) demonstrate excellent progression-free survival and overall survival on ibrutinib compared with cases harboring multiple TP53 hits. Testing TP53 deletion/mutation combining FISH and deep next-generation sequencing should be performed for a correct patient evaluation.See related article by Brieghel et al., p. 4531.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...

